FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Potassium Phosphate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 15 USDMF, 1 CEP/COS, 8 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 76 FDA Orange Book, 23 Europe, 14 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML), SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML), SOLUTION;INTRAVENOUS - 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML), SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML), SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 7 Rochem International Inc, 19 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 13 Kirsch Pharma, 1 ACG Worldwide, 15 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 28 BASF, 1 Bioplus Life Sciences, 5 Cassava Pharma, 3 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Esteem Industries, 3 Finar, 9 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 39 Roquette, 8 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 39 Thickeners and Stabilizers, 37 Parenteral, 35 Disintegrants & Superdisintegrants, 33 Direct Compression, 32 Topical, 31 Taste Masking, 29 Granulation, 25 Controlled & Modified Release, 24 Solubilizers, 21 Chewable & Orodispersible Aids, 20 Lubricants & Glidants, 18 Film Formers & Plasticizers, 14 Co-Processed Excipients, 10 Emulsifying Agents, 7 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 13 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 15 Regulatory FDF Prices

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ Xls

Filters

SOLUTION;INTRAVENOUS - 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML)

SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML)

SOLUTION;INTRAVENOUS - 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML)

SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML)

SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Potassium Phosphate

Potassium Phosphate

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

28 API Suppliers

15 USDMF

1 CEP/COS

8 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers

76 FDA Orange Book

23 Europe

14 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML)

SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML)

SOLUTION;INTRAVENOUS - 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML)

SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML)

SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Evonik

7 Rochem International Inc

19 SPI Pharma

4 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Pfanstiehl

13 Kirsch Pharma

1 ACG Worldwide

15 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 Avesta Pharma

28 BASF

1 Bioplus Life Sciences

5 Cassava Pharma

3 CD Formulation

2 Clariant

10 Corel Pharma Chem

6 DFE Pharma

2 Esteem Industries

3 Finar

9 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

10 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

39 Roquette

8 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

1 Symrise

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem